International Prostate Cancer Foundation
About
Survivors
Education
Donate
Resources
News
Awareness
0
International Prostate Cancer Foundation
About
Survivors
Education
Donate
Resources
News
Awareness
0
banner--news.png

RESEARCH & SUPPORT | EDUCATION | GLOBAL AWARENESS

News

 
Posts tagged metastatic hormone-sensitive prostate (mHSPC)
FDA approves darolutamide for mHSPC
FDA approves darolutamide for mHSPC
FDA -approved, Men's Health, Prostate Cancer Research, Resource CenterVipul PatelAugust 21, 2025FDA approved, Darolutamide, mHSPC, metastatic hormone-sensitive prostate (mHSPC), Prostate Cancer, Prostate Cancer Treatments
Treatment Intensification for Low-risk Metastatic Hormone-sensitive Prostate Cancer: The Time Is Now
Treatment Intensification for Low-risk Metastatic Hormone-sensitive Prostate Cancer: The Time Is Now
Combined Therapy, Education, Immunotherapy, Men's Health, Prostate Cancer Education, Prostate Cancer Research, ResearchVipul PatelJanuary 21, 2025Hormonal Intensification, Low-risk Metastatic Prostate Cancer, Prostate Cancer Treatments, metastatic hormone-sensitive prostate (mHSPC), Metastatic Prostate Cancer
 
 

home | resources | news | awareness | about | survivors | education | donate 

fightingprostatecancer@gmail.com
52 Riley Rd. | Suite 322  | Celebration, FL 34747
Your contribution will be receipted as per IRS guidelines. 
Read full disclaimer here.

 

The International Prostate Cancer's registered
charitable number is 27-2494047

©2018 website by 2u Creative; update ©2022